Avera McKennan Hospital & University Health Center
35
1
2
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
28.6%
10 terminated/withdrawn out of 35 trials
68.8%
-17.8% vs industry average
3%
1 trials in Phase 3/4
18%
4 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
Avera Cancer Sequencing and Analytics Protocol (ASAP)
Role: lead
Living Well With Serious Illness "Wicokuje Sica Tuha Akisniya Wiconi": Wawokiya Health Advocate Intervention
Role: collaborator
Node Negative, Invasive Breast Cancer Single Fraction IOERT
Role: lead
Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast
Role: lead
Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors
Role: lead
A Survey of Physician and Molecular Tumor Board Perspectives on the Clinical Utility and Usability of Cellworks Singula™ and Ventura™ Reports in Facilitating Patient Treatment Decisions for Pan-Cancer Patients
Role: lead
Intra-Operative Electron Boost and Hypofractionated Whole-Breast Irradiation During Breast-conserving Treatment (BCT)
Role: collaborator
Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)
Role: collaborator
Infant Care Practices Study
Role: lead
Exploring Potential Associations Between Rurality and Hopelessness in IHD Patients
Role: collaborator
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Role: lead
Continuous Temperature Measurement for Syndromic Surveillance
Role: lead
A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With ALS
Role: lead
Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers
Role: lead
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
Role: lead
Identifying Molecular Drivers of Cancer
Role: lead
Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis
Role: lead
Pharmacogenetic Testing in an Outpatient Population of Patients With Depression
Role: lead
Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes
Role: lead
Pharmacogenomics and Effective Treatment With Clopidogrel
Role: lead